ARIAD Pharmaceuticals, Inc. · Cambridge, MA United States ·(NASDAQ (GM): ARIA)
Company Description
View ARIAD Pharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window ARIAD Pharmaceuticals is exploring the myriad possibilities for new cancer treatments. The firm's lead drug candidate deforolimus targets solid tumors and hematological cancers. The drug blocks the cellular functions essential to the disease process by basically starving cancerous cells. The development-stage biotech is developing the drug in partnership with Merck . Deforolimus has also shown promise in preventing blockage in blood vessels, so the company has partnered with medical device firms Icon Medical and Medinol to develop drug-eluting stents. ARIAD is researching another compound, AP24534, as a possible treatment for chronic myeloid leukemia and other malignancies. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key ARIAD Pharmaceuticals, Inc. Financials
| Company Type | Public - NASDAQ (GM): ARIA Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $7.1 |
| 2008 Employees | 150 |
ARIAD Pharmaceuticals, Inc. Executives
25 executives listed for ARIAD Pharmaceuticals, Inc.'s Cambridge, MA location.
| Title | Name & Bio | Contact |
| Chairman, President, and CEO | Harvey Berger | Network |
| SVP, CFO, and Treasurer | Edward Fitzgerald | Network |
| VP Information Technology and Operations | Kelly Schmitz | Network |
Competition
Competitive Landscape for ARIAD Pharmaceuticals, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top ARIAD Pharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!